Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Oragenics Inc (OGEN).
Oragenics, Inc. successfully executed an underwriting agreement to sell 1.4 million shares at $1.50 each, raising $2.1 million before expenses, with options for over-allotment and additional warrants. The underwriters purchased shares at a slightly lower price and received warrants exercisable at $1.875. This strategic financial move, which closed on March 1, 2024, aims to strengthen the company’s financial position, with the details filed with the SEC and shared in a press release to keep investors informed.
For a thorough assessment of OGEN stock, go to TipRanks’ Stock Analysis page.